CONTEXT THERAPEUTICS INC. Basic Shares Outstanding (Weighted Average)
CONTEXT THERAPEUTICS INC. (CNTX) reported Basic Shares Outstanding (Weighted Average) of 95.18 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- CONTEXT THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 95.18M shares, a 0.00% decline year-over-year.
- CONTEXT THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 95.18M shares, a 0.00% decline year-over-year.
- CONTEXT THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 95.18M shares, a 16.18% increase year-over-year.
- CONTEXT THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 95.19M shares, a 18.27% increase year-over-year.
- CONTEXT THERAPEUTICS INC. weighted average number of shares outstanding, basic for fiscal 2025 was 95.19M shares, a 62.94% increase from fiscal 2024.
- CONTEXT THERAPEUTICS INC. weighted average number of shares outstanding, basic for fiscal 2024 was 58.42M shares, a 265.88% increase from fiscal 2023.
- CONTEXT THERAPEUTICS INC. weighted average number of shares outstanding, basic for fiscal 2023 was 15.97M shares, a 0.00% change from fiscal 2022.
- CONTEXT THERAPEUTICS INC. weighted average number of shares outstanding, basic for fiscal 2022 was 15.97M shares, a 463.44% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 95.18M shares 10-Q · filed 2026-08-05 | 95.18M shares 10-Q · filed 2026-08-05 | 95.18M shares derived: average of 3 quarters · filed 2026-08-05 | 95.18M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 95.18M shares 10-Q · filed 2026-05-06 | 95.18M shares derived: average of 2 quarters · filed 2026-05-06 | 95.18M shares derived: average of 3 quarters · filed 2026-05-06 | 95.18M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 95.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 95.18M shares derived: average of 2 quarters · filed 2026-03-23 | 95.19M shares derived: average of 3 quarters · filed 2026-08-05 | 95.19M shares 10-K · filed 2026-03-23 |
| 2025-09-30 | 95.19M shares 10-Q · filed 2025-11-05 | 95.19M shares derived: average of 2 quarters · filed 2026-08-05 | 95.19M shares 10-Q · filed 2025-11-05 | 91.87M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 95.19M shares 10-Q · filed 2026-08-05 | 95.19M shares 10-Q · filed 2026-08-05 | 90.77M shares derived: average of 3 quarters · filed 2026-08-05 | 88.20M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 95.19M shares 10-Q · filed 2026-05-06 | 88.56M shares derived: average of 2 quarters · filed 2026-05-06 | 85.87M shares derived: average of 3 quarters · filed 2026-05-06 | 78.14M shares derived: average of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | 81.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 81.21M shares derived: average of 2 quarters · filed 2026-03-23 | 72.46M shares derived: average of 3 quarters · filed 2026-03-23 | 58.42M shares 10-K · filed 2026-03-23 |
| 2024-09-30 | 80.48M shares 10-Q · filed 2025-11-05 | 67.72M shares derived: average of 2 quarters · filed 2025-11-05 | 50.58M shares 10-Q · filed 2025-11-05 | 41.84M shares derived: average of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | 54.96M shares 10-Q · filed 2025-08-06 | 35.46M shares 10-Q · filed 2025-08-06 | 28.96M shares derived: average of 3 quarters · filed 2025-08-06 | 25.71M shares derived: average of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | 15.97M shares 10-Q · filed 2025-05-07 | 15.97M shares derived: average of 2 quarters · filed 2025-05-07 | 15.97M shares derived: average of 3 quarters · filed 2025-05-07 | 15.97M shares derived: average of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | 15.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 15.97M shares derived: average of 2 quarters · filed 2025-03-20 | 15.97M shares derived: average of 3 quarters · filed 2025-03-20 | 15.97M shares 10-K · filed 2025-03-20 |
| 2023-09-30 | 15.97M shares 10-Q · filed 2024-11-06 | 15.97M shares derived: average of 2 quarters · filed 2024-11-06 | 15.97M shares 10-Q · filed 2024-11-06 | 15.97M shares derived: average of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | 15.97M shares 10-Q · filed 2024-08-07 | 15.97M shares 10-Q · filed 2024-08-07 | 15.97M shares derived: average of 3 quarters · filed 2024-08-07 | 15.97M shares derived: average of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | 15.97M shares 10-Q · filed 2024-05-08 | 15.97M shares derived: average of 2 quarters · filed 2024-05-08 | 15.97M shares derived: average of 3 quarters · filed 2024-05-08 | 15.97M shares derived: average of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | 15.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 15.97M shares derived: average of 2 quarters · filed 2024-03-21 | 15.97M shares derived: average of 3 quarters · filed 2024-03-21 | 15.97M shares 10-K · filed 2024-03-21 |
| 2022-09-30 | 15.97M shares 10-Q · filed 2023-11-09 | 15.97M shares derived: average of 2 quarters · filed 2023-11-09 | 15.97M shares 10-Q · filed 2023-11-09 | 14.54M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 15.97M shares 10-Q · filed 2023-08-09 | 15.97M shares 10-Q · filed 2023-08-09 | 14.07M shares derived: average of 3 quarters · filed 2023-08-09 | 10.64M shares derived: average of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | 15.97M shares 10-Q · filed 2023-05-10 | 13.12M shares derived: average of 2 quarters · filed 2023-05-10 | 8.87M shares derived: average of 3 quarters · filed 2023-05-10 | 6.74M shares derived: average of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | 10.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 5.32M shares derived: average of 2 quarters · filed 2023-03-22 | 3.66M shares derived: average of 3 quarters · filed 2023-03-22 | 2.83M shares 10-K · filed 2023-03-22 |
| 2021-09-30 | 361.07K shares 10-Q · filed 2022-11-09 | 357.95K shares derived: average of 2 quarters · filed 2022-11-09 | 355.09K shares 10-Q · filed 2022-11-09 | 353.39K shares derived: average of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | 354.83K shares 10-Q · filed 2022-08-11 | 352.05K shares 10-Q · filed 2022-08-11 | 350.83K shares derived: average of 3 quarters · filed 2022-08-11 | 350.22K shares derived: average of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | 349.24K shares 10-Q · filed 2022-05-11 | 348.83K shares derived: average of 2 quarters · filed 2022-05-11 | 348.68K shares derived: average of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | 348.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | 348.40K shares derived: average of 2 quarters · filed 2022-03-23 | 348.37K shares 10-K · filed 2022-03-23 | |
| 2020-09-30 | 348.38K shares 10-Q · filed 2021-12-02 | 348.35K shares 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |